XBiotech competitorsClear all

XBiotech's top competitors include Praxis Precision Medicines and RAPT Therapeutics.
XBiotech
XBiotech
XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
Praxis Precision Medicines
Praxis Precision Medicines
Praxis Precision Medicines is a company that develops therapies intended for patients and families affected by complex and debilitating brain disorders.
RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
Founding Date
Founding Date
2005
Founding Date
2015
Founding Date
2015
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Austin, US HQ
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
603% increase
Employees
50
Employees
64
Valuation ($)
Valuation ($)
477.6 m
Valuation ($)
831.2 m
Valuation ($)
671.5 m
Twitter followers
Twitter followers
270
Twitter followers
150
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
373218
Alexa Website Rank
N/A
Alexa Website Rank
324199
Employee Rating
Employee Rating
2.9
Employee Rating
N/A
Employee Rating
4.7

Financial

Revenue (est.)
Revenue (est.)
$44m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$5m (FY, 2020)
Net income
Net income
($11.2m) (FY, 2020)
Net income
($61.8m) (FY, 2020)
Net income
($52.9m) (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 131.9m
Total funding raised
$ 176m
For sources of this data, please see the company profile

View company profiles

Praxis Precision Medicines
HQ
Cambridge, US
Employees
50

Praxis Precision Medicines is a company that develops therapies intended for patients and families affected by complex and debilitating brain disorders.

View company
RAPT Therapeutics
HQ
South San Francisco, US
Employees
64

RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.

View company